In this Quick Case, Endocrinologist Dr Ramy Bishay reviews the evidence for semaglutide in type 2 diabetes and CKD, outlines its relevance and impact on glycaemic, renal and cardiovascular outcomes based on clinical trial evidence, and explains how to navigate PBS access and prescribing requirements (5 mins).
